Ual role of toll-receptors in regulation of antitumorous immunity the role of genetic factors in the development of occupational bronchial asthma

Immunologiya

Volumn , Issue 1, 2010, Pages 52-55

  Chikileva, I O ^a   Karaulov, A V ^a   Anisimova, N Yu ^a   Kiselevsky, M V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857966382     PISSN: 02064952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Aderem A., Wevitch R. J. Toll-like receptors in the induction of the innate immune response//Nature. - 2000. - Vol. 406. - P. 782-787.
2. Baniyash M. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response//Nat. Rev. Immunol. - 2004. - Vol. 4. - P. 675-687. (Pubitemid 39223074)
3. Beutler B. Inferences, question and possibilities in Toll-like receptor signaling//Nature. - 2004. - Vol. 430. - P. 257-263. (Pubitemid 38902439)
4. Beutler B. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases//Immunol. Rev. - 2009. - Vol. 227. - P. 248-263.
5. Beutler B. TPi;P and innate immunity//Blood. - 2009. - Vol. 113. - P. 1399-1407.
6. Chen K., Huang J., Gong W. et al. Toll-like receptors in inflammation, infection and cancer//Int. Immunopharmacol. - 2007. - Vol. 7. - P. 1271-1280.
7. Conroy H., Marshall N. A., Mills K. H. TπP ligand suppression or enhancement of Tper. cells? A double-edged sword in immunity to tumors//Oncogene. - 2008. - Vol. 27. - P. 168-180.
8. Ezemitchi A. V., Vaknin I., Cohen-Daniel L. et al. TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs//J. Immunol. - 2006. - Vol. 177. - P. 4763-4772. (Pubitemid 44469811)
9. Fosters. L., Medzfiitov R. Gene-specific control of the TllP-in-duced inflammatory response//Clin. Immunol. - 2009. - Vol. 130. - P. 7-15.
10. Fukata M., Abreu M. T. Role of Toll-like receptors in gastrointestinal malignancies//Oncogene. - 2008. - Vol. 7. - P. 234-243.
11. Callina G, Dolcetti L., Serafini P. et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells//J. Clin. Invest. - 2006. - Vol. 116. - P. 2777-2790. (Pubitemid 44511641)
12. Goriely S., Molle C., Nguyen M. et al. Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TI1P4) - and TIP3-induced IL-12p35 gene activation//Blood. - 2006. - Vol. 107. - P. 1078-1084. (Pubitemid 43156308)
13. + T cell response//J. Immunol. - 2007. - Vol. 17. - P. 5429-5433. (Pubitemid 46674336)
14. Hassan F., Islam S., Tumurkhuu G. et al. Intracellular expression of Toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide//BMC Cancer. - 2006. - Vol. 6. - P. 281-289.
15. He W., Liu Q., Wang L et al. TπP4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance//Mol. Immunol. - 2007. - Vol. 44. - P. 2850-2859. (Pubitemid 46412506)
16. Huang B., Zhao J., Li H. et al. Toil-like receptors on tumor cells facilitate evasion of immune surveillance//Cancer Res. - 2005. - Vol. 65. - P. 5009-5014. (Pubitemid 40827306)
17. Huang B., Pan P. K, Li Q. et al. GM+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell energy in tumor-bearing host//Cancer Res. - 2006. - Vol. 66. - P. 1123-1131. (Pubitemid 43165981)
18. Huang B., Zhao J., Shen S. et al. Listeria monocytogenes promotes tumor growth via tumor cell Toll-like receptor 2 signaling//Cancer Res. - 2007. - Vol. 67. - P. 4346-4352. (Pubitemid 46815083)
19. Huang B., Zhao J., Keless J. C. et al. TπP signaling by tumor and immune cells: a double-edged sword//Oncogene. - 2008. - Vol. 27. - P. 218-224.
20. Jain V. V., Kitagaki K., Businga T. et al. CpG-oligodeoxynucle-otides inhibit airway remodeling in a murine model of chronic asthma//J. Allergy Clin. Immunol. - 2002. - Vol. 110. - P. 867-872. (Pubitemid 36005873)
21. Jarnicki A. G., Lysaght J., Todryk S., Mills H. Suppression of antitumor immunity by IL-10 and TGF-p-producing T cells infiltrating the growing tumor influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cell//J. Immunol. - 2006. - Vol. 177. - P. 896-904. (Pubitemid 44036590)
22. Jasani B., Navabi H., Adams M. Ampligen: A potential Toll-like 3 receptor adjuvant for immunotherapy of cancer//Vaccine. - 2009. - Vol. 27. - P. 3401-3404.
23. Jego C., Bataille R., Geffroy-Luseau A. et al. Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors//Leukemia. - 2006. - Vol. 20. - P. 1130-1137. (Pubitemid 43797308)
24. Kelly M. G, Alvero A. B., Chen R. et al. TπP-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer//Cancer Res. - 2006. - Vol. 66. - P. 3859-3868.
25. Killeen S. D., Wang J. H., Andrews E. J. et al. Exploitation of the Toll-like receptor system in cancer a doubled-edged sword?//Br. J. Cancer. - 2006. - Vol. 95. - P. 247-252. (Pubitemid 44187583)
26. Killeen S. D., Wang J. H., Andrews E. J., Redmond H. P. Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TπP-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system//Br. J. Cancer. - 2009. - Vol. 100. - P. 1589-1602.
27. Van Der Kleij D., Latz E., Brouwers J. F. et al. A novel host-parasite lipid cross-talk: schistosomal lysophosphatidylserine activates Toll-like receptor 2 and affects immune polarization//J. Biol. Chem. - 2002. - Vol. 277. - P. 48122-48129. (Pubitemid 35470760)
28. Kundu S. D., Lee C., Billips B. K. et al. The Toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells//Prostate. - 2008. - Vol. 68. - P. 223-229. (Pubitemid 351186234)
29. Lavelle E. C., McNeela E., Armstrong M. E. et al. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation//J. Immunol. - 2003. - Vol. 171. - P. 2384-2392. (Pubitemid 37025545)
30. Levine D. B. The hospital for the ruptured and crippled: William Bradley Coley, Third Surgeon-in-Chief 1925-1933//HSS J. - 2008. - Vol. 4. - P. 1-9.
31. Lyakh I., Trinchieri G., Provezza L. et al. Regulation of inter-leukin-12/interleukin-23 production and the T-helper 17 response in humans//Immunol. Rev. - 2008. - Vol. 226. - P. 112-131.
32. Makarenkova V. P., Bansal V., Matta B. M. et al. CDllb+/Gr-I+ myeloid suppressor cells cause T cell dysfunction after traumatic stress//J. Immunol. - 2006. - Vol. 176. - P. 2085-2094. (Pubitemid 43201655)
33. Van Maren W. W., Jacobs J. F., De Vries I. J. et al. Toll-like receptor signaling on Tper.s: to suppress or not to suppress?//Immunology. - 2008. - Vol. 124. - P. 445-452. (Pubitemid 351962555)
34. Mercier B. C., Cottalorda A., Coupet C. A. et al. TπP2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal//J. Immunol. - 2009. - Vol. 182. - P. 1860-1867.
35. Mills K. H. Regulatory T cells: friend or foe in immunity to infection?//Nat. Rev. Immunol. - 2004. - Vol. 4. - P. 841-855. (Pubitemid 39490760)
36. Mocellin S., Panelli M. C., Wang E., Nagorsen D. The dual role of IL-10//Trends Immunol. - 2003. - Vol. 24. - P. 36-43. (Pubitemid 35462111)
37. Murad Y. M., Clay T. M., Lyerly H. K, Morse M. A.//Expert Opin. Biol. Ther. - 2007. - Vol. 7. - P. 1257-1266.
38. Muzio M., Bertilaccio M. T., Simonetti G. et al. The role of Tolllike receptors in chronic B cell malignancies//Leukemia and Lymphoma. - 2009. - Vol. 11. - P. 1-8.
39. Niezielska I., Niedzielski Z., Tkacz M. et al. Toll-like receptors and the tendency ol normal mucous membrane to transform to polypor colorectal cancer//J. Physiol. Pharmacol - 2009. - Vol. 60. - P. 65-71.
40. Paterson H. M., Murphy T. J., Purcell E. J. et al. Injury primes the innate immune system for enhanced Toll-like receptor reactivity//J. Immunol. - 2003. - Vol. 171. - P. 1473-1483. (Pubitemid 36900082)
41. Salaun B., Coste I., Rissoan M. C. et al. TπP3 can directly trigger apoptosis in human cancer cells//J. Immunol. - 2006. - Vol. 176. - P. 4894-4901.
42. Salaun B., Lebecque S., Matikainen S. et al. Toll-like receptor 3 expressed by melanoma cells as a target for therapy?//Clin. Cancer Res. - 2006. - Vol. 13. - P. 4565-4574.
43. Sato M., Harada K., Yoshida H. et al. Therapy for oral squamous cell carcinoma by tegafur and streptococcal agent OK-432 in combination with radiotherapy: association of the therapeutic effect with differentiation and apoptosis in the cancer cells//Apoptosis. - 1997. - Vol. 2. - P. 27-238.
44. Schmidt J., Welsch T., Jäger D. et al. Intratumoural injection of the Toll-like receptor-2/6 agonist' macrophage activating li-popeptide-2c in patients with pancreatic carcinoma: a phase 1/II trial//Br. J. Cancer. - 2007. - Vol. 97. - P. 598-604. (Pubitemid 47339882)
45. Spaner D. E., Masellis A. Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia//Leukemia. - 2007. - Vol. 21. - P. 53-60. (Pubitemid 44921834)
46. Tillman D. K., Caroll M. T. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience//Cutis. - 2007. - Vol. 79. - P. 241-248.
47. Tsan M. F., Gao B. Heat shock proteins and immune system//J. Leukoc. Biol. - 2009. - Vol. 85. - P. 905-910.
48. Vaknin I., Blinder L., Wang L. et al. A common pathway mediated through Toll-like receptors leads to T-and natural killer-cell immunosuppression//Blood. - 2008. - Vol. 111. - P. 1437-1447. (Pubitemid 351213431)
49. Vasselon T., Detmers P. A. Toll receptors: a central element in innate responses//Infect, and Immun. - 2002. - Vol. 3. - P. 1033-1041. (Pubitemid 34163371)
50. Weeratna R. D., Makinen S. R., McCluskie M. J. et al. TPi;P agonists as vaccine adjuvants: comparison of CpG ODN and Resiqui-mod (R-848)//Vaccine. - 2005. - Vol. 23. - P. 5263-5270. (Pubitemid 41443432)
51. Zeromski J., Mozer-Lisewska I., Kaczmarek M. Significance of Toll-like receptors expression in tumor growth and spreading: A short review//Cancer Res. - 2006. - Vol. 66. - P. 3859-3868.